statistical analysis of a masterchart of a study
Budget: ₹600 – ₹1,500 INR
statistical analysis of a masterchart which contains data of 350 patients.To conduct a comprehensive statistical analysis addressing these questions, we will focus on the following approaches for each aspect:
1. **Impact of Clinical and Demographic Factors on Patient Outcomes**
**Method**:
- Perform logistic regression to assess the effect of *age*, *gender*, and *comorbidities* on the likelihood of discharge, death, or renal recovery in Acute Kidney Injury (AKI) patients.
- Chi-square tests or Fisher's exact tests to analyze the role of pre-existing conditions (*hypertension, diabetes, etc.*) on mortality.
2. **Prognostic Factors Associated with AKI Outcomes**
**Method**:
- Use logistic regression to investigate the impact of *nephrotoxic drugs* on outcomes.
- Analyze biochemical, radiological, ECG, and echo findings using regression or ANOVA to check their association with discharge or death.
- Cox proportional hazards model to analyze therapeutic factors like *ventilator use*, *RRT modality* (*IHD, SLED, peritoneal dialysis*), and *vasopressors* in relation to discharge, death, renal recovery, or 6-month dependence.
3. **Length of Stay and Treatment Effectiveness**
**Method**:
- Correlation analysis (Pearson or Spearman) to assess the relationship between *length of stay* in the ICU/ward and recovery or mortality.
4. **Fluid Management and Outcome**
**Method**:
- Cox regression or survival analysis to study the impact of *positive or negative fluid balance* on survival rates.
- Chi-square or logistic regression for determining the correlation between specific *fluid management strategies* (e.g., normal saline or balanced salt solution) and patient recovery.
5. **Diagnostic and Prognostic Tools**
**Method**:
- Use multivariable regression models to assess the predictive power of *diagnostic markers* (ECG findings, infection markers, ultrasound results) on patient outcomes.
- ROC curves for evaluating the diagnostic performance of early markers.
6. **Comorbidities and Their Influence on AKI Outcomes**
**Method**:
- Logistic regression to analyze the influence of *cardiovascular comorbidities* (e.g., myocardial infarction, heart failure) on AKI prognosis.
- Stratified analysis to compare outcomes between patients with and without *diabetes* or *hypertension*.
7. **Subgroup Analysis for Specific Populations (Pregnant, Snake Bite, Sepsis, Drug-induced AKI)**
**Method**:
- Stratified or subgroup analysis to explore differences in parameters and outcomes among specific patient populations (pregnant, snake-bite, sepsis, etc.).
- Survival analysis for different subgroups to see if their outcome metrics differ significantly.
8. **Time Points and AKI Progression**
**Method**:
- Mixed-effects models or repeated measures ANOVA to analyze the progression of *serum creatinine* and other biochemical markers over time (D0, D3, D7, D30, D180) and their association with overall prognosis.
9. **Predictive Value of Early Diagnostic Indicators**
**Method**:
- Logistic regression or survival analysis to determine if early diagnostic indicators like *ECG* or *ultrasound* can predict prolonged ICU stays or higher mortality.
- ANOVA to analyze the effect of *urine output measurements* (oliguria, anuria) at admission on outcomes.
10. **Infection and AKI Outcomes**
**Method**:
- Cox regression to explore the relationship between *infection-related factors* (e.g., sepsis, positive infection workup) and the likelihood of mortality.
- Subgroup analysis to assess whether infection-positive patients have worse outcomes despite treatment.
11. **Impact of Fluid Overload**
**Method**:
- Kaplan-Meier survival curves and Cox regression to assess the impact of *fluid overload* on mortality and ICU stay.
- Analyze if there is a specific *fluid balance threshold* beyond which outcomes significantly worsen.
12. **Mortality Risk Factors**
**Method**:
- Logistic regression to identify independent predictors of mortality, including *age, vasopressor use, infection*, and *comorbidities*.
- Chi-square test to compare mortality risks between *community-acquired AKI (CAAKI)* and *hospital-acquired AKI (HAAKI)*.
WANT THESE within 48 hours
1. **Impact of Clinical and Demographic Factors on Patient Outcomes**
**Method**:
- Perform logistic regression to assess the effect of *age*, *gender*, and *comorbidities* on the likelihood of discharge, death, or renal recovery in Acute Kidney Injury (AKI) patients.
- Chi-square tests or Fisher's exact tests to analyze the role of pre-existing conditions (*hypertension, diabetes, etc.*) on mortality.
2. **Prognostic Factors Associated with AKI Outcomes**
**Method**:
- Use logistic regression to investigate the impact of *nephrotoxic drugs* on outcomes.
- Analyze biochemical, radiological, ECG, and echo findings using regression or ANOVA to check their association with discharge or death.
- Cox proportional hazards model to analyze therapeutic factors like *ventilator use*, *RRT modality* (*IHD, SLED, peritoneal dialysis*), and *vasopressors* in relation to discharge, death, renal recovery, or 6-month dependence.
3. **Length of Stay and Treatment Effectiveness**
**Method**:
- Correlation analysis (Pearson or Spearman) to assess the relationship between *length of stay* in the ICU/ward and recovery or mortality.
4. **Fluid Management and Outcome**
**Method**:
- Cox regression or survival analysis to study the impact of *positive or negative fluid balance* on survival rates.
- Chi-square or logistic regression for determining the correlation between specific *fluid management strategies* (e.g., normal saline or balanced salt solution) and patient recovery.
5. **Diagnostic and Prognostic Tools**
**Method**:
- Use multivariable regression models to assess the predictive power of *diagnostic markers* (ECG findings, infection markers, ultrasound results) on patient outcomes.
- ROC curves for evaluating the diagnostic performance of early markers.
6. **Comorbidities and Their Influence on AKI Outcomes**
**Method**:
- Logistic regression to analyze the influence of *cardiovascular comorbidities* (e.g., myocardial infarction, heart failure) on AKI prognosis.
- Stratified analysis to compare outcomes between patients with and without *diabetes* or *hypertension*.
7. **Subgroup Analysis for Specific Populations (Pregnant, Snake Bite, Sepsis, Drug-induced AKI)**
**Method**:
- Stratified or subgroup analysis to explore differences in parameters and outcomes among specific patient populations (pregnant, snake-bite, sepsis, etc.).
- Survival analysis for different subgroups to see if their outcome metrics differ significantly.
8. **Time Points and AKI Progression**
**Method**:
- Mixed-effects models or repeated measures ANOVA to analyze the progression of *serum creatinine* and other biochemical markers over time (D0, D3, D7, D30, D180) and their association with overall prognosis.
9. **Predictive Value of Early Diagnostic Indicators**
**Method**:
- Logistic regression or survival analysis to determine if early diagnostic indicators like *ECG* or *ultrasound* can predict prolonged ICU stays or higher mortality.
- ANOVA to analyze the effect of *urine output measurements* (oliguria, anuria) at admission on outcomes.
10. **Infection and AKI Outcomes**
**Method**:
- Cox regression to explore the relationship between *infection-related factors* (e.g., sepsis, positive infection workup) and the likelihood of mortality.
- Subgroup analysis to assess whether infection-positive patients have worse outcomes despite treatment.
11. **Impact of Fluid Overload**
**Method**:
- Kaplan-Meier survival curves and Cox regression to assess the impact of *fluid overload* on mortality and ICU stay.
- Analyze if there is a specific *fluid balance threshold* beyond which outcomes significantly worsen.
12. **Mortality Risk Factors**
**Method**:
- Logistic regression to identify independent predictors of mortality, including *age, vasopressor use, infection*, and *comorbidities*.
- Chi-square test to compare mortality risks between *community-acquired AKI (CAAKI)* and *hospital-acquired AKI (HAAKI)*.
WANT THESE within 48 hours